Status:
RECRUITING
Effects of an Automatic Oxygen Titration System in People With Hypoxemia During Exercise Training
Lead Sponsor:
Schön Klinik Berchtesgadener Land
Conditions:
Hypoxaemia
Chronic Lung Disease
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Long-term oxygen therapy is a fundamental treatment modality for patients with chronic hypoxaemic lung disease. Typically, oxygen is administered at a constant flow rate. However, due to fluctuating a...
Detailed Description
Rationale: Hypoxaemia is common in people with chronic lung disease and can affect exercise tolerance. Oxygen therapy is then recommended. Oxygen supplementation is usually delivered at constant oxy...
Eligibility Criteria
Inclusion
- Chronic lung disease
- Hypoxemia (pO2\< 55mmHg) under room air conditions (rest or during exercise) or SpO2\<88% during exercise
- established Long-term oxygen therapy or given indication for a Long-term oxygen therapy/ supplemental oxygen therapy for exercise
- Age: 18 to 80 years
- Participation in an inpatient pulmonary rehabilitation program (Schoen Klinik BGL, Germany)
- Written informed consent
Exclusion
- \- Acute exacerbation of underlying pulmonary disease requiring cessation of exercise training.
Key Trial Info
Start Date :
August 14 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2024
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06545851
Start Date
August 14 2023
End Date
November 30 2024
Last Update
August 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinikum Berchtesgadener Land, Schön Kliniken
Schönau am Königssee, Bavaria, Germany, 83471